Autoimmune Diseases

Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of…

Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected…

<!-- Name:DistributionId Value:8790089 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8745384 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

- Lead compound IOS-1002 to be studied as mono and combination therapy in patients with advanced solid tumors- First patients to be enrolled in Q1, 2023 Schlieren (Zurich Area),…

Chandigarh: In a major setback for patients with serious health problems, several specialised marker tests have come to a halt in the PGI as it has stopped purchase of reagents used for…

Selbyville, Delaware, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The lyophilized injectable drugs market value is projected to reach USD 740 billion by 2030, according to a new research report…

The study, "The influence of the macular carotenoids on women's eye and brain health," was published in. "The idea is that men get a lot of the diseases that tend to kill you, but women get…

Selbyville, Delaware, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Global antibody therapy market value projected to cross USD 445 billion by 2028, according to a new research report by Global…

Experts consider environmental factors as a major culprit behind the upsurge of cases. The study findings may further help to find a cure for these rapidly spreading autoimmune conditions.…